ASCENTAGE PHARMA GROUP INTERNATIONAL Logo

ASCENTAGE PHARMA GROUP INTERNATIONAL

Biopharma developing small-molecule drugs for cancer, HBV, and age-related diseases.

AAPG | NDAQ

Overview

Corporate Details

ISIN(s):
US04390B1052
LEI:
Country:
United States of America
Address:
68 XINQING ROAD, 0 SUZHOU , JIANGSU
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Ascentage Pharma Group International is a global, clinical-stage biopharmaceutical company focused on developing novel therapies for cancers, chronic hepatitis B, and age-related diseases with unmet medical needs. The company's core R&D strategy targets apoptosis pathways, specializing in small-molecule drug candidates that inhibit protein-protein interactions. Its robust pipeline features potential first-in-class and best-in-class assets, including the approved third-generation BCR-ABL inhibitor olverembatinib and the Bcl-2 inhibitor lisaftoclax. With over 40 clinical trials active globally, Ascentage Pharma has secured numerous priority and orphan drug designations from the US FDA and China's CDE. The company actively pursues a global strategy through clinical and commercial collaborations with leading pharmaceutical companies and research institutions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all ASCENTAGE PHARMA GROUP INTERNATIONAL filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for ASCENTAGE PHARMA GROUP INTERNATIONAL

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for ASCENTAGE PHARMA GROUP INTERNATIONAL via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
CALTH. Inc Logo
Develops AI-powered rapid diagnostic solutions for point-of-care and self-testing.
South Korea 402420
CAMBRIDGE NUTRITIONAL SCIENCES PLC Logo
Develops and manufactures diagnostic tests for food sensitivity and gut health.
United Kingdom CNSL
Camp4 Therapeutics Corp Logo
Developing RNA-based therapies to upregulate genes for rare metabolic and CNS disorders.
United States of America CAMP
Camurus Logo
Develops long-acting medicines for severe chronic diseases using advanced drug delivery.
Sweden CAMX
Clinical-stage biopharma developing novel cancer drugs aiming for fewer side effects.
Japan 4575
Candel Therapeutics, Inc. Logo
Developing off-the-shelf viral immunotherapies to help the immune system fight solid tumors.
United States of America CADL
Can-Fite BioPharma Ltd. Logo
Clinical-stage biopharma developing oral drugs for cancer, inflammatory, liver & metabolic diseases.
United States of America CANF
Can-Fite BioPharma Ltd. Logo
Develops oral small-molecule drugs targeting A3AR for oncology and inflammatory diseases.
Israel CANF
Cannovum Cannabis AG Logo
Importer & producer of medical cannabis, expanding into recreational cultivation infrastructure.
Germany 27N0
Canopy Growth Corp Logo
Produces diverse cannabis products for medical and recreational markets globally.
United States of America CGC

Talk to a Data Expert

Have a question? We'll get back to you promptly.